PCI's team of qualified persons assume responsibility for all stages of the process, safeguarding patients including the audit of the supply chain for GMP compliance in addition to certification of products for use in clinical trials.
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.
The growing need for convenient and tamper-free packaging has proliferated the demand for blister packaging. Learn about contract blister packaging services that can produce several different packaging forms.
At Kymanox, the Manufacturing Science & Technology (MS&T) and Supply Chain team, with its global experience in the biopharmaceutical and medical device industries, provides support for all product development phases from early clinical to post-commercial life cycle management.